Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Onyx Weight Loss vs Trinity Meds

Onyx Weight Loss
Graded #358

Lower grade

vs+2.4000000000000057
Trinity Meds
Graded #302

Higher grade

The verdict

Trinity Meds takes it — 61.2/100 to 58.8/100.

Trinity Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trinity Meds is a telehealth weight-loss program aimed at military women, spouses and veterans, offering compounded GLP-1 medication on an all-inclusive flat monthly rate: semaglutide at $149/month and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrinity Meds +21
43
64
Dose & formulationEven
64
64
Clinical oversightOnyx Weight Loss +1
75
74
Labs & monitoringOnyx Weight Loss +11
63
52
FulfillmentTrinity Meds +15
53
68
Contract termsOnyx Weight Loss +35
55
20
Onyx Weight Loss · left barTrinity Meds · right bar

The numbers

MetricOnyx Weight LossTrinity Meds
WeighScore58.8/10061.2/100
GradeCC
Scorecard rank#358#302
Semaglutide$228/mo (starting dose, compounded)$149/mo (compounded)
Tirzepatide$280/mo (starting dose, compounded)$199/mo (compounded)
Coverage8 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Onyx Weight Loss

Graded #358 · C

Strengths

  • Competitive entry pricing: semaglutide from $228/mo and tirzepatide from $280/mo with medication + supplies included
  • Nurse-practitioner-led care: founder Tasha Vangile FNP-C (20+ years) and Stephanie Robison APRN-CNP (27 years experience)
  • Low-cost $99/mo GLP-1 microdosing option for patients who prefer a gradual titration start
  • Strive Pharmacy partnership implies compounded 503A-quality supply chain from a known pharmacy
  • Multi-modal clinic: GLP-1 + peptides + HRT + nutrition coaching available under one provider team

Where it loses points

  • Only 8 states (NC, CO, ME, VT, VA, IA, NH, PA) — excludes the majority of the US
  • No LegitScript certification; credentialing evidence limited to local 2025 Best of Iredell award
  • Specific drug names (semaglutide/tirzepatide) never stated on website; compounded status inferred, not disclosed
  • Labs not included or mentioned; no baseline bloodwork protocol published
  • Pricing shown as 'Starting at' with no dose-escalation tier pricing disclosed publicly
Trinity Meds

Graded #302 · C

Strengths

  • All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
  • Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
  • No insurance required, FSA eligible, with free shipping to your door
  • Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the assessment
  • Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
  • No terms-of-service page is posted (only a privacy policy)
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • Military framing is marketing; the program and pricing are open to anyone who qualifies

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard